Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
rare disease drugs
3
×
anemia
beta-thalassemia
boston
boston top stories
clinical trials
acceleron pharmaceuticals
alexion pharmaceuticals
bioverativ
bluebird bio
cedric francois
celgene
clinical trials apellis pharmaceuticals
cold agglutinin disease
complement 3 glomerulopathy
crispr therapeutics
dae gon ha
drugs
eculizumab
fda
gene editing
gene therapy
geograph atrophy
global blood therapeutics
h. lundbeck a/s
imara
investing
lentiglobin
lundbeckfonden ventures
luspatercept
myelodysplastic syndrome (mds)
national top stories
new enterprise associates
new york
new york blog main
new york top stories
What
blood
3
×
disease
3
×
drug
activity
advances
alexion’s
apellis
approval
assets
based
celgene
celgene’s
cell
cited
clinic
companies
currently
developer
disorder
experimental
fda
filed
files
flurry
genetic
head
imara
ipos
key
nasdaq
nj
offer
option
patients
pharmaceuticals
pipeline
plan
rare
research
revealed
Language
unset
Current search:
disease
×
blood
×
" rare disease drugs "
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}